Abstract
A rapid and specific liquid chromatographic mass/mass (LC-MS/MS) method is described for the assessment of valsartan (VAL) in human plasma after protein precipitation (PPT) and liquid-liquid extraction (LLE) techniques. The column used in PPT method was Eclipse Plus column, (C18, 50 mm x 2.1 mm, 1.8 μm) with a mobile phase ratio of 0.1% formic acid: methanol (15:85, v/v) while the column used in LLE method was Agilent column, (C18, 50 mm x 4.6 mm, 5 μm) with a mobile phase ratio of 0.1 % formic acid: acetonitrile (20:80, v/v). The assay was found to be linear over the ranges of 20-10000 and 25-8000 ng/ mL VAL using the PPT and LLE, respectively. The developed method was validated following the united states food and drug administration (US - FDA) recommendations and directions from the European Medical Agency (EMA). The method was validated for sensitivity, selectivity, linearity, accuracy and precision, recovery, dilution integrity, matrix effect, carryover in the matrix, and analyte stability during both short- and long-term sample processing and storage.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
